Cargando…
177. Use of Electronic Best Practice Alert (BPA) to Reduce Inappropriate Testing for Clostridium difficile infection (CDI) at a Tertiary Care Center
BACKGROUND: Clostridium difficile assays are unable to differentiate between active infection and asymptomatic carriage. Failure to account for noninfectious causes of diarrhea in hospitalized patients may contribute to overdiagnosis of CDI, leading to unnecessary treatment and increased cost of car...
Autores principales: | Mills, John P, Chang, Robert, Rao, Krishna, Zimmerman, Chris, Yoon, Hee-Won, Dombecki, Carolyn, Washer, Laraine L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254553/ http://dx.doi.org/10.1093/ofid/ofy210.190 |
Ejemplares similares
-
2344. Evaluation of a Best Practice Alert (BPA) to Reduce Inappropriate Testing for Clostridium difficile Infection (CDI) Within a Multi-Hospital System
por: Dare, Ryan K, et al.
Publicado: (2019) -
New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008) -
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015) -
2365. Volatile Metabolite-Based Detection of Clostridium difficile Infection (CDI)
por: Aloum, Obadah, et al.
Publicado: (2019) -
Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)